{"id":"W2809887875","doi":"10.1186/s12959-018-0176-2","title":"COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study","year":2018,"lang":"en","type":"article","venue":"Thrombosis Journal","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Janssen Pharmaceuticals; Janssen Scientific Affairs; Bayer","keywords":"Medicine; Rivaroxaban; Quality of life (healthcare); Venous thromboembolism; Cancer; Low molecular weight heparin; Intensive care medicine; Anticoagulant; Vitamin K antagonist; Thrombosis; Internal medicine; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003265296,0.0002408574,0.0006823892,0.000230956,0.0004704632,0.00005198776,0.0001292344,0.00003861753,0.0001820865],"category_scores_gemma":[0.0000219779,0.0001437174,0.0001774359,0.0002484632,0.000107664,0.000120396,0.00006833716,0.0001116237,0.000003848011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000269958,"about_ca_system_score_gemma":0.00009179403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001102283,"about_ca_topic_score_gemma":0.0002818698,"domain_scores_codex":[0.9984975,0.00005727674,0.0003935469,0.0002955332,0.0003846095,0.0003714942],"domain_scores_gemma":[0.9987089,0.00007186393,0.0003214467,0.0002422763,0.0004890728,0.0001664548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005367837,0.08602351,0.1612232,0.0004776101,0.01997929,0.000009147087,0.09667722,0.0001093548,0.0009764469,0.0004040957,0.008589245,0.6201631],"study_design_scores_gemma":[0.006127198,0.04806588,0.9371129,0.0007856374,0.002507713,0.000006501014,0.002926039,0.00007614593,0.001002458,0.0001625465,0.001041904,0.0001851],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932052,0.0001754573,0.001832193,0.0006569506,0.0005164972,0.003456586,0.00004793498,0.00001340653,0.0000958111],"genre_scores_gemma":[0.9979807,0.000333384,0.0004854014,0.0001256763,0.0005214937,0.0004493106,0.00001039091,0.00003547599,0.00005819789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7758897,"threshold_uncertainty_score":0.5860627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03361475804794766,"score_gpt":0.3513641826824143,"score_spread":0.3177494246344666,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}